1. Medtech Insight

Minute Insight: Abbott’s Aveir VR To Take On Medtronic’s Micra In US Leadless Pacemaker Market

 
• By Reed Miller

The US FDA approved Aveir VR to treat significant bradycardia on 4 April. It is the world’s only leadless pacemaker with Abbott’s proprietary mapping capability that helps physicians correctly position the device inside the right ventricle.

Minute Insight
• Source: Informa/Alamy

The US Food and Drug Administration approved a premarket approval application (PMA) for Abbott’s Aveir VR single-chamber leadless pacemaker, the company announced on 4 April.

Aveir VR is indicated for the treatment of people with significant bradycardia, chronic atrial fibrillation, and severe physical disability, but contraindicated for people who have

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight